Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.


TSX:PRN - Post by User

Post by cleareyeon Nov 06, 2021 1:23pm
234 Views
Post# 34095932

Conference Call - worth listening

Conference Call - worth listening I used a link from a very helpful stocktwits poster. You can find it there or maybe the copy and paste below will give you an idea where to look.

I walked away with a positive feeling that the actual patient use of the technology is growing by 20%  per quarter, that there is a backlog of orders, no orders have been dropped, no installed units have been left idle after installation and that the only delays are covid19 related.

The extreme drop in share price was undoubtedly exasperated by the low trade volume, low float, and generally brutal market action in this sector.

When people want in rather than out, I expect some leaps in the upward direction. I would buy more but my percent holding of Profound in my portfolio is already way over my self-imposed limit for one stock.


Cool explanations provided on the $PROF cc transcript fool.com/earnings/call-tran...


<< Previous
Bullboard Posts
Next >>